Thomas Lenz has been active and a partner in a number of companies, where he has worked with product development, manufacture and sales. Several products have been patented with Thomas as the innovator.
The products have been in various areas such as fitness, car safety, medical technology as well as in the sports area. For ten years he worked with the development of youth football and was also a cup general for two of Sweden’s largest football cups. Thomas has also been responsible for the development of a mountain facility for land development, marketing and sales.
In 2010, Thomas founded an alcolock company, which has operations in several European countries. The Company was listed on the stock exchange in 2016 and was acquired by an American group two years later. In recent years, he has worked internationally both as a consultant and in-house, mainly with probiotic products.
Erik has been involved in building several brands and companies via the market & sales side. Two of these have become, and still are, public companies, one of which was acquired by an American company in 2018.
Former football player who after injury became a professional golfer and competed during the 1990s. After interrupted International Business studies at SDSU in the USA, due to football injury, studied Media Strategy at IHM Business School in Stockholm.
Erik has also been active in success-oriented organizational profiling and studied strategic leadership in various forms at the Corporate University of Stockholm. His professional strengths are relationship building and leadership. Erik has held a number of leading roles with a lot of personnel responsibility and is an experienced project manager. (ISO 9001 and 14001)
Committed experienced Entrepreneur with vast experience in the financial sector. Mainly in banking, insurance and privately owned credit market companies.
Key words are ”together” and ”solution-oriented”.
Pharmacist basically with 25 years of experience from the life science industry where he worked both nationally and internationally at various companies. Hamid has great knowledge of preclinical research, conducted field-based clinical research on malaria in Vietnam and was among the first to graduate in clinical trials in Sweden.
Over the years, Hamid has held various leading positions at companies such as Pharmacia, Pfizer, Eli Lilly and served as CEO of an international CRO company, Parexel. Since 2010, Hamid has founded a number of different companies and has a very broad understanding and experience of running businesses indifferent development phases.
Today, he runs the Barnik Invest Group with a focus on financing, recruitment and consulting services within Life Science and helps Startup companies to commercial success
Has a Master’s degree in Biomedical Laboratory Science and has 14 years of experience in the life science industry, from preclinical and development phase to clinical research and quality work in the pharmaceutical industry as a consultant at Merck, GSK and Sanofi, among others.
Furthermore, Sara has experience of project management of validation studies in the field of medical technology and have acted as operational manager and as head of the outsourcing unit at Medicorent. She is now a partner in the Barnik Invest Group.
Obtained an Honour’s degree (Psychology and Physiology) at Newcastle-upon-Tyne University(1974), and a PhD, Uppsala University, Uppsala, Sweden (1979). Between1978-1988, employed by Astra Läkemedel AB with the position of Head of CNSDrugs.
Appointment as Professor and Chair of Biological Psychology, University of Gothenburg from 1988.
Guestor Visiting Professor at: University of Hawaii at Manoa (1994),
Örebro University (1996-2006),
Karlstad University (2000-2004),
Kalmar University (2003-2013),
Madrid University (1991-2009),
Sapienza University, Rome (2013-)
and received an Outstanding Lifetime Achievement Award from St. Joseph’s College, North Point (2010);
Honorary Doctorship, Professorship and Membership Awards from the Polish Academy of Science Pharmacological Society (May, 2013);
and the Sansone Award (April, 2014):
School of Medicine,Washington University, St. Louis, Missouri. Dr. Waymans Mullin Award (Best Journal Article, with AC Andersson et al.)Society for Police and Criminal Psychology (2018),
H-index is currently 49, with over 7880 citations Senior professor at Gothenburg university since 30th October 2016 until 30th March 2020.
Versatile Entrepreneur ranging from Media to General store in the Stockholm Archipelago. Marketing and Economics at IHM Business School. Interests are Golf and life in the Archipelago, and a hidden talent – played Olympic qualifiers in Curling. Passionate about Milmed Unico AB. The feeling of being able to give something back to humanity “For Life”.
Has worked in Life Science for 22 years. She has held various positions in both the big pharma and the CRO industry. Chose 2009 to leave big pharma to develop further in Life Science and then switched to CRO (Clinical Research Organization). Has worked actively with board work since 2014 when also attending the Board Academy’s education. Performed UGL 2017.
CRO, Medicorent Int. AB – Director of Clinical Operations Pharmacist basically. Worked in life science and clinical trials for over 20 years, held various roles both in large global pharmaceutical companies and smaller consulting companies. Has been head of department at Clinical Operations and also vice president of a staff-owned CRO company. Board member for five years. Has worked with various therapeutic areas, including asthma and allergies, diabetes, oncology and cardiovascular diseases in Sweden and with Nordic responsibility.
Regulatory Partner, Atran Pharmaceutical AB – Senior Regulatory Affairs Consultant Pharmacist basically. Worked in regulatory affairs and quality assurance for about 20 years. Worked mainly in industry, but also at the Medical Products Agency. Had various roles in pharmaceutical companies both in RA and QA, ranging from building up RA / QA / PV department, working in management team for listed pharmaceutical company to pure expert roles then mainly in Regulatory Affairs and CMC. Has been a senior consultant for the past 10 years.
Previous positions and assignments: Director General of the Swedish Price and Cartel Board (now the Swedish Competition Authority). CEO of Apoteksbolaget ABChairman of ADA AB, after sale to TAMRO OY DeputyChairman of TAMRO.Chairman of SECURUM AB. Vice Chairman of the Stockholm Stock Exchange and member of the Companies Committee, Board experience from state-owned operating companies (e.g. Vattenfall) and from privately owned companies (both listed and unlisted) Board assignments in the Swedish Employers’ Association and the Swedish Wholesale Association / Swedish TradeCarried out about fifteen SOU investigations / Negotiation assignments in various industries as chairman, secretary or member / expert. Has in recent years worked through board assignments and as an advisor, e.g. for Venture Capital Funds.
Head of the Laboratory of Neuromorphology, of the Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Rome. Responsible for the Executive Protocol Agreement between Sapienza University of Rome, Italy and Rutgers University, New Brunswick / Piscataway, USA 2000-2017 Professor of Human Anatomy, Sapienza University of Rome, Italy1982-2000 Assistant Professor of Human Anatomy, Sapienza University of Rome, Italy 1980-1981 Associate Scientist Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania, USA1978-1980 Fellow, Laboratory of Cell Biology, CNR, Rome, ItalyProfessor of Human Anatomy, Dept. of Medico-Surgical Sciences and Biotechnologies Sapienza University of Rome, Italy
Skills and competences:– Cell Biology– Morphological and morphometric analyses– Immunochemical and immunohistochemical analyses– Neurotrophic and Neurotoxic factors– Stress-related disorders
Main Research Topics– Study of comorbidity of Alzheimer’s disease and cerebrovascular disorders– Role of the cell populations and mediators of the immune response in the etiopathogenesis of atherosclerosis– Crosstalk Central Nervous System-Immune System– Development of new methods for degenerative medicine– Positive epigenetic developments
Elena De Falco
Production and Lab ManagerWorked on manufacturing and research with Milmed in the 90’s in Moscow. Employed when Milmed AB started in Sweden in 2007, participated in all research studies carried out at Uppsala and Linnaeus University between 2008-2017. University degree in biochemistry and food science. Has worked in Milmed Unico AB from the start in 2018, manufacturing Milmed for ongoing research studies and for future production of dry Milmed (ALNOZINE™) at Jästbolaget.
Rose Mary Erixon
Preclinical scientist, Master degree, Ph.D. candidateHas worked in various business areas between the years 1998 to 2018, then started a Masters education at the University of Gothenburg with Trevor Archer as supervisor.Selected employers; Volvo PV, Sweden Consultant (PR, trade fairs, launches of new products / cars), Gizmondo Ltd., Project, Marketing Manager, (Southern and Eastern Europe).Construction of Italian Olivetti (certified cash register systems / control boxes in consultation with the Swedish Tax Agency).Project manager, infrastructure development and construction in Croatia with the Chinese and Croatian governments.